Skip to main content
48°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
TG Therapeutics, Inc. - Common Stock
(NQ:
TGTX
)
34.15
-0.09 (-0.26%)
Streaming Delayed Price
Updated: 10:33 AM EDT, May 23, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about TG Therapeutics, Inc. - Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today
May 01, 2023
These three biotech stocks were on the volatile side today.
Via
The Motley Fool
12 Health Care Stocks Moving In Monday's Intraday Session
May 01, 2023
Via
Benzinga
Top 1% Biotech TG Therapeutics Obliterates Bullish Sales Calls — And Rockets
May 01, 2023
The company makes a one-hour, twice-a-year infusion for multiple sclerosis.
Via
Investor's Business Daily
IVERIC bio, Ascendis Pharma And Other Big Stocks Moving Higher In Monday's Pre-Market Session
May 01, 2023
U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session. Apollomics, Inc. (NASDAQ: APLM) surged 58.4% to $7.35 in pre-market trading...
Via
Benzinga
Here Are The Best-Performing Industry ETFs And Major Stock Contributors In April
April 30, 2023
It's a good time to look at how the major U.S. stock industry ETFs performed this month, as April comes to an end. In April, we saw the broader U.S.
Via
Benzinga
Where TG Therapeutics Stands With Analysts
April 17, 2023
Via
Benzinga
Analyst Ratings for TG Therapeutics
March 31, 2023
Via
Benzinga
Where TG Therapeutics Stands With Analysts
March 01, 2023
Via
Benzinga
Here's How Much $100 Invested In TG Therapeutics 10 Years Ago Would Be Worth Today
February 07, 2023
Via
Benzinga
Earnings Scheduled For May 1, 2023
May 01, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million.
Via
Benzinga
The Latest Analyst Ratings for TG Therapeutics
January 24, 2023
Via
Benzinga
Here's How Much $1000 Invested In TG Therapeutics 10 Years Ago Would Be Worth Today
January 19, 2023
Via
Benzinga
3 Top Biotech Stocks Defying the Bear Market
April 25, 2023
All three companies have therapies with strong sales potential.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
April 20, 2023
Via
Benzinga
Stock Market Rally Mixed Amid Recession Worries; JPMorgan Headlines Earnings: Weekly Review
April 14, 2023
The Nasdaq was flat while the Dow rose amid rising recession fears.
Via
Investor's Business Daily
Get In Now. 7 Stocks That Are Set to Soar.
April 13, 2023
While it’s always difficult to determine which stocks to buy might break out imminently, speculators should watch these ideas.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
April 12, 2023
Via
Benzinga
Why Shares of TG Therapeutics Soared on Tuesday
April 11, 2023
Early reports of strong sales for its recently approved multiple sclerosis drug gave the stock a jolt.
Via
The Motley Fool
Wall Street Struggles For Direction As Oil Inches Higher
April 11, 2023
Stocks are mixed, as investors look ahead to this week's economic data.
Via
Talk Markets
PriceSmart, CarMax, Cognyte Software And Other Big Stocks Moving Higher On Tuesday
April 11, 2023
U.S. stocks traded mixed, with the Dow Jones gaining over 50 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Kalera Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 11, 2023
Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 164% to $3.86 after the company announced it launched ChatGPT-enabled smart eyewear.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 10, 2023
Via
Benzinga
Top-Notch Biotech TG Therapeutics Logs 'Solid Jump' In Sales; Shares Rocket
April 10, 2023
Shares are closing in on a buy point out of a consolidation.
Via
Investor's Business Daily
Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 10, 2023
Gainers PLx Pharma Inc. (NASDAQ: PLXP) gained 128.2% to $0.2399 after dropping over 13% on Thursday.
Via
Benzinga
Micron Technology, Greenbrier Companies And Other Big Stocks Moving Higher On Monday
April 10, 2023
U.S. stocks traded lower, with the Nasdaq Composite falling over 100 points on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 10, 2023
Gainers Barnes & Noble Education, Inc. (NYSE: BNED) jumped 39% to $2.39 after the company posted better-than-expected quarterly sales.
Via
Benzinga
Top 5 Health Care Stocks That May Collapse In February
February 13, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Cramer Likens This Stock To 'A Fine Merlot': It's Down 1% In 2023, So 'I Would Buy All You Can Right Here'
February 08, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Parker-Hannifin Corp (NYSE: PH) is "just the kind of industrial I’ve been recommending."
Via
Benzinga
Earnings Scheduled For February 28, 2023
February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.
Via
Benzinga
TG Therapeutics Stock 300% Rally Has Legs Yet
February 08, 2023
There's further upside in the region of 30% yet to be realized, which should be more than enough to get even the more risk averse investor interested.
Via
MarketBeat
Exposures
COVID-19
Product Safety
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.